Product Images Tecfidera

This appears to be a table showing percentages of subjects with confirmed progression of disability at different time points during a study. The study appears to have had two groups, one receiving placebo and the other receiving TECFIDERA 240 mg AID. Confirmed progression of disability is defined as at least a 10 point increase on the EDSS (a scale used to measure disability in multiple sclerosis patients) from a baseline EDSS >= 10, confirmed for 12 weeks or a 15% increase on the EDAS. More contextual information is required to provide a detailed description.*

Tecfidera is a prescription medication available in the form of 60 delayed-release capsules containing dimethyl fumarate. The medication should be swallowed whole and comes with a warning that it should only be dispensed in its original package. The NDC code for this medication is 64406-006-02.*

Tecfidera is a medication in the form of delayed-release capsules containing 120 mg of dimethyl fumarate. It is recommended to store the medication at 15°C to 30°C and protect it from light. The dosage requires taking one capsule orally twice a day. The package insert contains more detailed dosage and administration instructions. The medication is available only via prescription. For more information and support, individuals can visit the Tecfidera website or call 1-800-456-2255. The text also includes a unique identifier code (NDC 64406-005-01) for the medication.*

This appears to be a product description for Tecfidera, which is a medication in the form of delayed-release capsules containing dimethyl fumarate. The recommended dosage is one capsule taken orally twice a day, and the capsules should be stored between 15°C to 30°C. The package contains 14 capsules, and the product should be protected from light. The text also provides a National Drug Code (NDC) for identification purposes, and a support contact phone number.*

Tecfidera is a medication in the form of delayed-release capsules containing 120mg of dimethyl fumarate used for treating multiple sclerosis. The capsules must be stored at temperatures between 16°C to 30°C and protected from light. The capsules are dispensed in the original package and must be swallowed whole. The dosage is one capsule by mouth twice a day. The package insert must be seen for dosage and administration. For more information and support on Tecfidera, you can call 1-800-456-2255 or visit Tecfidera.com. The remaining text is not available.*

This is a medication instruction sheet for Tecfidera, a delayed-release capsule containing Dimethyl fumarate, for patients taking it for the first 30 days. The starter pack comes with a bottle of 120mg capsules for days 1 to 7 and a bottle of 240 mg capsules for days 8 to 30. The instructions recommend taking one 120mg capsule twice a day for the first 7 days, followed by one 240mg capsule twice a day for the remaining 23 days. The medication should be taken whole and stored at between 15°C to 30°C. The package contains 14 capsules of 120mg and 46 capsules of 240mg. For dosage and administration instructions, refer to the back panel. Additional information and support can be obtained from the provided phone number and the Tecfidera website.*